Karus Therapeutics Ltd., of Southhampton, UK, appointed James Bristol, Jeff Evans, Fritz Frickel, Richard Groves, Chris Reilly, Phill Hawkins, Len Stephens and Bart Vanhaesebroeck to its new scientific advisory board
CoCo Therapeutics Ltd., of London, named Steve Butcher chief operating officer, and the company also appointed Clive Ballard, Jonathan Corcoran, Roy Lobb, Andrew Wood and Steve Butcher to its clinical and scientific advisory board
Fate Therapeutics Inc., of San Diego, appointed Christian Weyer president and CEO...Heptares Therapeutics Ltd., of Welwyn Garden City, UK, added Roger M. Perlmutter to its board
Oncos Therapeutics Ltd., of Helsinki, Finland, added Kapil Dhingra, Lee Helman, Kevin Harrington, Eva Galanis, Luca Gianni and Elke Jager to its clinical advisory board (CAB
Addex Therapeutics Ltd., of Geneva, named Graham Dixon chief scientific officer and head of research...and Thomas Rollins senior vice president of program and portfolio management
ImmunoCellular Therapeutics Ltd., of Woodland Hills, Calif., appointed Richard Chin chairman of the compensation committee and added him to its board and the audit committee
Heptares Therapeutics Ltd., of Welwyn Garden City, UK, appointed Daniel Grau president...It also named Robert B. Shapiro and Jeffrey B. Kindler to its board
Immune System Therapeutics Ltd., of Sydney, Australia, appointed Calum McKinlay CEO...Medivir AB, of Huddinge, Sweden, appointed Maris Hartmanis president and CEO
Medgenics Inc., of Misgav, Israel, added Isaac Blech and Raymond Dean Hautamaki to its board...Oncos Therapeutics Ltd., of Helsinki, Finland, appointed Mikael von Euler chief medical officer
ImmunoCellular Therapeutics Ltd., of Los Angeles, appointed George Peoples, Constantine Ioannides and Cohava Gelber to its scientific advisory board...operations and also appointed Jon Terrett vice president of oncology at its San Jose, Calif
Pro-Cure Therapeutics Ltd., of York, UK, appointed Alastair J. Riddell nonexecutive chairman...XOMA Ltd., of Berkeley, Calif., appointed Susan Kramer vice president, project and alliance management
Dendreon Corp., of Seattle, elected Ian Clark and Pedro Granadillo to its board...Heptares Therapeutics Ltd., of Welwyn Garden City, UK, appointed Barry Kenny chief business officer
Novacta Therapeutics Ltd., of Welwyn Garden City, UK, appointed David Pompliano to its board...Pharminox Ltd., of Nottingham, UK, appointed Lee Arnold, Adrian Harris and Robert Jackson to its scientific advisory board
BioCeramic Therapeutics Ltd., of London, appointed Stephan Rietiker to its board of directors...Ensysce Biosciences Inc., of Houston, appointed Lynn Kirkpatrick president and CEO
Shield Therapeutics Ltd., of London, named Julian Howell group medical director and VP of drug development, and added Lynn Drummond to its board